{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:11:21Z","timestamp":1773277881957,"version":"3.50.1"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1097\/qai.0b013e318299c3f4","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T18:41:26Z","timestamp":1371062486000},"page":"S221-S227","source":"Crossref","is-referenced-by-count":39,"title":["Can Combination Prevention Strategies Reduce HIV Transmission in Generalized Epidemic Settings in Africa? The HPTN 071 (PopART) Study Plan in South Africa and Zambia"],"prefix":"10.1097","volume":"63","author":[{"given":"Sten H.","family":"Vermund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Ayles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nulda","family":"Beyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1258\/0956462042395195","article-title":"Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.","volume":"15","author":"Reid","year":"2004","journal-title":"Int J STD AIDS"},{"key":"R2-19-20210131","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":". Scaling up interventions to achieve global tuberculosis control: progress and new developments.","volume":"379","author":"Raviglione","year":"2012","journal-title":"Lancet"},{"key":"R3-19-20210131","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrmicro2797","article-title":". Global tuberculosis control: lessons learnt and future prospects.","volume":"10","author":"Lienhardt","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"R4-19-20210131","first-page":"35","article-title":"Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs.","volume":"13","author":"Pai","year":"2012","journal-title":"Discov Med"},{"key":"R5-19-20210131","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1473-3099(11)70145-1","article-title":". Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review.","volume":"11","author":"Uyei","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R6-19-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/tmi.12029","article-title":". Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review.","volume":"18","author":"Legido-Quigley","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"suppl 4","key":"R7-19-20210131","doi-asserted-by":"crossref","first-page":"D97","DOI":"10.1016\/j.vaccine.2011.12.003","article-title":"The challenge of malaria eradication in the twenty-first century: research linked to operations is the key.","volume":"29","author":"Breman","year":"2011","journal-title":"Vaccine"},{"key":"R8-19-20210131","doi-asserted-by":"crossref","first-page":"e1000397","DOI":"10.1371\/journal.pmed.1000397","article-title":"A research agenda for malaria eradication: health systems and operational research.","volume":"8","year":"2011","journal-title":"PLoS Med"},{"key":"R9-19-20210131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(13)70047-1","article-title":". Assessment of the RTS, SAS01 malaria vaccine.","volume":"13","author":"Moorthy","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R10-19-20210131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(11)60877-5","article-title":". HIV prevention transformed: the new prevention research agenda.","volume":"378","author":"Padian","year":"2011","journal-title":"Lancet"},{"key":"R11-19-20210131","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":". Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"R12-19-20210131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":". Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R13-19-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":". Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R14-19-20210131","doi-asserted-by":"crossref","first-page":"e1001260","DOI":"10.1371\/journal.pmed.1001260","article-title":". HIV treatment as prevention: the utility and limitations of ecological observation.","volume":"9","author":"Smith","year":"2012","journal-title":"PLoS Med"},{"key":"R15-19-20210131","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11904-013-0155-y","article-title":"Combination prevention: new hope for stopping the epidemic.","volume":"10","author":"Vermund","year":"2013","journal-title":"Curr HIVAIDS Rep"},{"key":"R16-19-20210131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11904-010-0063-3","article-title":". Combination HIV prevention: significance, challenges, and opportunities.","volume":"8","author":"Kurth","year":"2011","journal-title":"Curr HIVAIDS Rep"},{"key":"R17-19-20210131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.socscimed.2013.01.011","article-title":". Effects of home-based voluntary counselling and testing on HIV-related stigma: findings from a cluster-randomized trial in Zambia.","volume":"81","author":"Jurgensen","year":"2013","journal-title":"Soc Sci Med"},{"key":"R18-19-20210131","doi-asserted-by":"crossref","first-page":"e1001351","DOI":"10.1371\/journal.pmed.1001351","article-title":". Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis.","volume":"9","author":"Sabapathy","year":"2012","journal-title":"PLoS Med"},{"key":"R20-19-20210131","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1473-3099(11)70060-3","article-title":". Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.","volume":"11","author":"Sweat","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R21-19-20210131","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10461-010-9807-8","article-title":". Demonstration and evaluation of a peer-delivered, individually-tailored, HIV prevention intervention for HIV-infected MSM in their primary care setting.","volume":"15","author":"Safren","year":"2011","journal-title":"AIDS Behav"},{"key":"R22-19-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/COH.0b013e32834f5cf2","article-title":"HIV treatment as prevention and HPTN 052.","volume":"7","author":"Cohen","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"R23-19-20210131","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11904-013-0152-1","article-title":"Antiretroviral therapy for prevention is a combination strategy.","volume":"10","author":"McNairy","year":"2013","journal-title":"Current HIVAIDS Rep"},{"key":"R24-19-20210131","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cct.2012.07.007","article-title":". Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples.","volume":"33","author":"Chen","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R25-19-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1740774512443594","article-title":"Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey.","volume":"9","author":"Cohen","year":"2012","journal-title":"Clin Trials"},{"key":"R26-19-20210131","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/infdis\/jir651","article-title":". Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.","volume":"204","author":"Eshleman","year":"2011","journal-title":"J Infect Dis"},{"key":"R27-19-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":". Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R28-19-20210131","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":". Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.","volume":"375","author":"Donnell","year":"2010","journal-title":"Lancet"},{"key":"R30-19-20210131","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1228160","article-title":". High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.","volume":"339","author":"Tanser","year":"2013","journal-title":"Science"},{"key":"R31-19-20210131","doi-asserted-by":"crossref","first-page":"e11068","DOI":"10.1371\/journal.pone.0011068","article-title":". Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.","volume":"5","author":"Das","year":"2010","journal-title":"PloS One"},{"key":"R32-19-20210131","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(11)60821-0","article-title":"Treatment as preventiona double hat-trick.","volume":"378","author":"Montaner","year":"2011","journal-title":"Lancet"},{"issue":"suppl 3","key":"R33-19-20210131","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/QAI.0b013e31825f3284","article-title":". Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US Presidents Emergency Plan for AIDS Relief.","volume":"60","author":"Chi","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 4","key":"R34-19-20210131","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1093\/cid\/cis003","article-title":". World Health Organization generic protocol to assess drug-resistant HIV among children 18 months of age and newly diagnosed with HIV in resource-limited countries.","volume":"54","author":"Bertagnolio","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R35-19-20210131","first-page":"454","article-title":"Effectiveness of condoms in preventing sexually transmitted infections.","volume":"82","author":"Holmes","year":"2004","journal-title":"Bull World Health Organ"},{"key":"R36-19-20210131","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2471\/BLT.11.094268","article-title":". Effects of condom social marketing on condom use in developing countries: a systematic review and meta-analysis, 1990-2010.","volume":"90","author":"Sweat","year":"2012","journal-title":"Bull World Health Organ"},{"key":"R37-19-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1071\/SH11011","article-title":"Progress and challenges to male and female condom use in South Africa.","volume":"9","author":"Beksinska","year":"2012","journal-title":"Sex Health"},{"key":"R38-19-20210131","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1071\/SH11037","article-title":"A review of the effectiveness and acceptability of the female condom for dual protection.","volume":"9","author":"Gallo","year":"2012","journal-title":"Sex Health"},{"key":"R39-19-20210131","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.1093166","article-title":"Population-level HIV declines and behavioral risk avoidance in Uganda.","volume":"304","author":"Stoneburner","year":"2004","journal-title":"Science"},{"issue":"suppl 3","key":"R40-19-20210131","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/QAI.0b013e31825f313b","article-title":". What took you so long the impact of PEPFAR on the expansion of HIV testing and counseling services in Africa.","volume":"60","author":"Marum","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R41-19-20210131","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1001\/jama.1992.03490230068030","article-title":". Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates.","volume":"268","author":"Allen","year":"1992","journal-title":"JAMA"},{"issue":"suppl 3","key":"R42-19-20210131","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAI.0b013e31825f315e","article-title":". PEPFARs evolving HIV prevention approaches for key populationspeople who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.","volume":"60","author":"Needle","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-19-20210131","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/COH.0b013e328354a0b5","article-title":". Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.","volume":"7","author":"Dutta","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"R44-19-20210131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1423-0410.2002.00198.x","article-title":". Pharmaco-economics of blood transfusion safety: review of the available evidence.","volume":"83","author":"van Hulst","year":"2002","journal-title":"Vox Sang"},{"key":"R46-19-20210131","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/QAD.0b013e3283543e83","article-title":". Antiviral agents and HIV prevention: controversies, conflicts, and consensus.","volume":"26","author":"Cohen","year":"2012","journal-title":"AIDS"},{"key":"R47-19-20210131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/eri.11.20","article-title":"Post-exposure prophylaxis for HIV infection.","volume":"9","author":"Rey","year":"2011","journal-title":"Expert Rev Anti-Infective Ther"},{"key":"R48-19-20210131","doi-asserted-by":"crossref","first-page":"e1003211","DOI":"10.1371\/journal.ppat.1003211","article-title":". Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study.","volume":"9","author":"Saez-Cirion","year":"2013","journal-title":"PLoS Pathog"},{"key":"R49-19-20210131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":". Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"R50-19-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":". Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"R51-19-20210131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":". Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R52-19-20210131","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":". Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R54-19-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":". Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"R55-19-20210131","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(00)02336-9","article-title":". Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials.","volume":"355","author":"Grosskurth","year":"2000","journal-title":"Lancet"},{"key":"R56-19-20210131","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/01.qai.0000127062.94627.31","article-title":". Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIVsexually transmitted disease intervention trials: a modeling study.","volume":"37","author":"White","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"R57-19-20210131","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/425274","article-title":". Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.","volume":"191","author":"Korenromp","year":"2005","journal-title":"J Infect Dis"},{"issue":"suppl 4","key":"R58-19-20210131","first-page":"S15","article-title":"Celum C, et al..","volume":"24","author":"Hayes","year":"2010","journal-title":"Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning AIDS"},{"key":"R59-19-20210131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1473-3099(12)70207-4","article-title":". Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial.","volume":"12","author":"Walson","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R60-19-20210131","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e32835ecba9","article-title":". Evaluation of impact of long-lasting insecticide-treated bed nets and point-of-use water filters on HIV-1 disease progression in Kenya.","volume":"27","author":"Walson","year":"2013","journal-title":"AIDS"},{"key":"R61-19-20210131","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(10)70093-1","article-title":"Effect of treating co-infections on HIV-1 viral load: a systematic review.","volume":"10","author":"Modjarrad","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R62-19-20210131","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1097\/QAD.0b013e328312c756","article-title":"Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.","volume":"22","author":"Modjarrad","year":"2008","journal-title":"AIDS"},{"key":"R63-19-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/QAI.0b013e3182511e42","article-title":". The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda.","volume":"60","author":"Webb","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R64-19-20210131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0140-6736(10)61457-2","article-title":". Effect of single-dose anthelmintic treatment during pregnancy on an infants response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial.","volume":"377","author":"Webb","year":"2011","journal-title":"Lancet"},{"key":"R65-19-20210131","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/649924","article-title":". Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial.","volume":"50","author":"Ndibazza","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R66-19-20210131","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/QAD.0b013e32830a502e","article-title":". Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.","volume":"22","author":"Walson","year":"2008","journal-title":"AIDS"},{"key":"R67-19-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/ni0413-413a","article-title":"Lessons learned from HIV-1 vaccine trials: new priorities and directions.","volume":"14","author":"McMichael","year":"2013","journal-title":"Nat Immunol"},{"key":"R68-19-20210131","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":". Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"key":"R72-19-20210131","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4155\/tde.10.74","article-title":"Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides.","volume":"1","author":"Fetherston","year":"2010","journal-title":"Ther Deliv"},{"key":"R73-19-20210131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IJWH.S36282","article-title":". Vaginal rings for delivery of HIV microbicides.","volume":"4","author":"Malcolm","year":"2012","journal-title":"Int J Womens Health"},{"key":"R74-19-20210131","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1002\/jps.22120","article-title":"Compartmental transport model of microbicide delivery by an intravaginal ring.","volume":"99","author":"Geonnotti","year":"2010","journal-title":"J Pharm Sci"},{"key":"R75-19-20210131","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1310\/hct1104-205","article-title":". Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.","volume":"11","author":"Lifson","year":"2010","journal-title":"HIV Clin Trials"},{"key":"R76-19-20210131","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/aid.2011.0284","article-title":". Primary drug resistance in South Africa: data from 10 years of surveys.","volume":"28","author":"Manasa","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R77-19-20210131","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2796.2011.02456.x","article-title":"HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.","volume":"270","author":"Nichols","year":"2011","journal-title":"J Intern Med"},{"key":"R78-19-20210131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(11)70141-4","article-title":". HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.","volume":"11","author":"Sigaloff","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R79-19-20210131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4314\/njm.v19i4.61956","article-title":"Antiretroviral drug resistanceimplications for HIVAIDS reduction in sub-Saharan Africa and other developing countries.","volume":"19","author":"Obiako","year":"2010","journal-title":"Niger J Med"},{"key":"R80-19-20210131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00007611-200204000-00009","article-title":". Protease inhibitor combination therapy and decreased condom use among gay men.","volume":"95","author":"DiClemente","year":"2002","journal-title":"South Med J"},{"key":"R81-19-20210131","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00002030-200203290-00013","article-title":". Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men.","volume":"16","author":"Ostrow","year":"2002","journal-title":"AIDS"},{"key":"R82-19-20210131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00002030-200401230-00021","article-title":". Homosexual men change to risky sex when perceiving less threat of HIVAIDS since availability of highly active antiretroviral therapy: a longitudinal study.","volume":"18","author":"Stolte","year":"2004","journal-title":"AIDS"},{"key":"R83-19-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200102160-00010","article-title":". Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection.","volume":"15","author":"Dukers","year":"2001","journal-title":"AIDS"},{"key":"R84-19-20210131","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/00002030-200309050-00014","article-title":". Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users.","volume":"17","author":"Tun","year":"2003","journal-title":"AIDS"},{"key":"R85-19-20210131","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/OLQ.0b013e31820d5a77","article-title":". HIVAIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs.","volume":"38","author":"MacKellar","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R86-19-20210131","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/QAD.0b013e3283552185","article-title":". Transitioning HIV care and treatment programs in southern Africa to full local management.","volume":"26","author":"Vermund","year":"2012","journal-title":"AIDS"},{"key":"R87-19-20210131","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1212353","article-title":"HIVAIDS. ARVs as HIV prevention: a tough road to wide impact.","volume":"334","author":"Shelton","year":"2011","journal-title":"Science"},{"key":"R88-19-20210131","doi-asserted-by":"crossref","first-page":"e5602","DOI":"10.1371\/journal.pone.0005602","article-title":". Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV.","volume":"4","author":"Ayles","year":"2009","journal-title":"PloS One"},{"key":"R89-19-20210131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1745-6215-9-63","article-title":". ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trial.","volume":"9","author":"Ayles","year":"2008","journal-title":"Trials"},{"key":"R90-19-20210131","doi-asserted-by":"crossref","first-page":"e7749","DOI":"10.1371\/journal.pone.0007749","article-title":". Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa.","volume":"4","author":"Shanaube","year":"2009","journal-title":"PloS One"},{"key":"R91-19-20210131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1740774508094747","article-title":". Restricted randomization of ZAMSTAR: a 2 x 2 factorial cluster randomized trial.","volume":"5","author":"Sismanidis","year":"2008","journal-title":"Clin Trials"},{"key":"R92-19-20210131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2334-12-183","article-title":". Field comparison of OraQuick ADVANCE Rapid HIV-12 antibody test and two blood-based rapid HIV antibody tests in Zambia.","volume":"12","author":"Zachary","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R94-19-20210131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/157016211798038515","article-title":"Universal testing and treatment as an HIV prevention strategy: research questions and methods.","volume":"9","author":"Hayes","year":"2011","journal-title":"Curr HIV Res"},{"key":"R96-19-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s10461-011-9929-7","article-title":". Acceptability of male circumcision among adolescent boys and their parents, Botswana.","volume":"16","author":"Jayeoba","year":"2012","journal-title":"AIDS Behav"},{"key":"R97-19-20210131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09540121.2011.608793","article-title":"Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland.","volume":"24","author":"Andersson","year":"2012","journal-title":"AIDS Care"},{"key":"R98-19-20210131","doi-asserted-by":"crossref","first-page":"e1001132","DOI":"10.1371\/journal.pmed.1001132","article-title":". Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.","volume":"8","author":"Njeuhmeli","year":"2011","journal-title":"PLoS Med"},{"key":"R99-19-20210131","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1097\/QAI.0b013e318285d449","article-title":". A Randomized Trial of Mogen Clamp versus Plastibell for Neonatal Male Circumcision in Botswana.","volume":"62","author":"Plank","year":"2013","journal-title":"J Acqui Immune Defic Syndr"},{"key":"R103-19-20210131","doi-asserted-by":"crossref","first-page":"e35491","DOI":"10.1371\/journal.pone.0035491","article-title":". Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.","volume":"7","author":"Rossenkhan","year":"2012","journal-title":"PloS One"},{"key":"R105-19-20210131","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/JVI.73.5.4427-4432.1999","article-title":". Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.","volume":"73","author":"Novitsky","year":"1999","journal-title":"J Virol"},{"key":"R106-19-20210131","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/157016211798038597","article-title":". Antiretroviral therapy in prevention of HIV and TB: update on current research efforts.","volume":"9","author":"Granich","year":"2011","journal-title":"Curr HIV Res"},{"key":"R107-19-20210131","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/COH.0b013e32834fc1df","article-title":". Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence.","volume":"7","author":"Barnighausen","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"R108-19-20210131","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/S0140-6736(10)60838-0","article-title":"HIV drugs for treatment, and for prevention.","volume":"375","author":"Dabis","year":"2010","journal-title":"Lancet"},{"key":"R109-19-20210131","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":". Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"key":"R110-19-20210131","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":". Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.","volume":"376","author":"Montaner","year":"2010","journal-title":"Lancet"},{"key":"R111-19-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/COH.0b013e32835b80dd","article-title":"Fifteen million people on antiretroviral treatment by 2015: treatment as prevention.","volume":"8","author":"Granich","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"R112-19-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1473-3099(12)70273-6","article-title":". Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.","volume":"13","author":"Chang","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R113-19-20210131","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/QAD.0b013e328360a4e5","article-title":". Cost-effectiveness of point-of-care viral load monitoring of ART in resource-limited settings: mathematical modelling study.","volume":"27","author":"Estill","year":"2013","journal-title":"AIDS"},{"key":"R114-19-20210131","doi-asserted-by":"crossref","first-page":"e57611","DOI":"10.1371\/journal.pone.0057611","article-title":". Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study.","volume":"8","author":"Estill","year":"2013","journal-title":"PloS One"},{"key":"R115-19-20210131","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/QAI.0b013e318227af37","article-title":". Evaluation of large-scale combination HIV prevention programs: essential issues.","volume":"58","author":"Padian","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R116-19-20210131","first-page":"315","article-title":". HIV-1 treatment as prevention: the good, the bad, and the challenges.","volume":"6","author":"Smith","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"R117-19-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.9745\/GHSP-D-12-00053","article-title":"Can we stop AIDS with antiretroviral-based treatment as prevention.","volume":"1","author":"Mills","year":"2013","journal-title":"Glob Health Sci Pract"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e318299c3f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:01:57Z","timestamp":1645747317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201307012-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":104,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318299c3f4","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}